upadacitinib

How long does Upadacitinib stay in your body?

The elimination half-life of upadacitinib is about 8 to 14 hours (mean terminal elimination half-life) — the time it takes the body to clear about half of it. As a rule of thumb, a medicine is mostly gone after roughly 4 to 5 half-lives, though this varies from person to person with age and kidney or liver function. This is the terminal (elimination) half-life the label reports for the parent drug, which is the active moiety — upadacitinib is not a prodrug, and the label explicitly states "No active metabolites have been identified," so there is no longer-lived active metabolite to account for. The label describes population effects as changes in exposure (AUC), not as changes in half-life: geriatric patients (>=65) showed no clinically meaningful PK difference; renal impairment raised AUC modestly (about 18%/33%/44% higher in mild/moderate/severe), with mild-to-moderate not considered clinically relevant; hepatic impairment raised AUC about 28% (mild, Child-Pugh A) and 24% (moderate, Child-Pugh B), and it was not studied in severe (Child-Pugh C) impairment.

This is general information, not medical advice. It doesn’t tell you when a drug test would read negative (tests detect substances for different, often longer, windows) or when it’s safe to take another dose — ask your pharmacist or prescriber. Source: RINVOQ (upadacitinib) FDA label — DailyMed, §12.3 Pharmacokinetics.

Frequently asked questions

What does Upadacitinib treat?

Upadacitinib (Upadacitinib) may be used to treat rheumatoid arthritis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

How does Upadacitinib work?

Upadacitinib is a janus kinase inhibitor. JAK inhibitors block Janus kinase enzymes inside immune cells. These enzymes normally pass along messages from inflammatory signals (cytokines) to relay proteins that switch on genes, so blocking them turns down the overactive immune signaling that drives diseases like rheumatoid arthritis.

How is Upadacitinib rated?

pharmaranks gives Upadacitinib a composite score of 3.4 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.

Is there a coupon or discount for Upadacitinib?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Upadacitinib. To pay less, Upadacitinib is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Upadacitinib?

Upadacitinib is marketed by Sandoz. You can see Sandoz's full profile, rating, and other products on pharmaranks.

Is Upadacitinib a brand-name or generic drug?

Upadacitinib is a generic medication; its active ingredient is Upadacitinib. Generics contain the same active ingredient as the brand-name original and are usually lower cost.

Is Upadacitinib available over the counter?

No. Upadacitinib is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Upadacitinib come in?

Upadacitinib is currently marketed as tablet, extended release and tablet, per the FDA's National Drug Code Directory.

What class of drug is Upadacitinib?

Upadacitinib is classified as janus kinase inhibitor, per the FDA's Established Pharmacologic Class.

Is Upadacitinib FDA-registered?

Upadacitinib is on record with the U.S. FDA under application number ANDA218792. You can verify this on its official FDA label.

Has Upadacitinib been recalled by the FDA?

Upadacitinib has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.

Is Upadacitinib safe?

There's no single safe-or-not verdict. pharmaranks gives Upadacitinib a recall-safety score of 68/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.